Cargando…

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”

Detalles Bibliográficos
Autores principales: Rabe, Thomas, Saenger, Nicole, Ebert, Andreas D., Roemer, Thomas, Tinneberg, Hans-Rudolf, De Wilde, Rudy Leon, Wallwiener, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304190/
https://www.ncbi.nlm.nih.gov/pubmed/30622959
http://dx.doi.org/10.1155/2018/6124628
_version_ 1783382306909585408
author Rabe, Thomas
Saenger, Nicole
Ebert, Andreas D.
Roemer, Thomas
Tinneberg, Hans-Rudolf
De Wilde, Rudy Leon
Wallwiener, Markus
author_facet Rabe, Thomas
Saenger, Nicole
Ebert, Andreas D.
Roemer, Thomas
Tinneberg, Hans-Rudolf
De Wilde, Rudy Leon
Wallwiener, Markus
author_sort Rabe, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-6304190
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63041902019-01-08 Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate” Rabe, Thomas Saenger, Nicole Ebert, Andreas D. Roemer, Thomas Tinneberg, Hans-Rudolf De Wilde, Rudy Leon Wallwiener, Markus Biomed Res Int Corrigendum Hindawi 2018-11-28 /pmc/articles/PMC6304190/ /pubmed/30622959 http://dx.doi.org/10.1155/2018/6124628 Text en Copyright © 2018 Thomas Rabe et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Rabe, Thomas
Saenger, Nicole
Ebert, Andreas D.
Roemer, Thomas
Tinneberg, Hans-Rudolf
De Wilde, Rudy Leon
Wallwiener, Markus
Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title_full Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title_fullStr Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title_full_unstemmed Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title_short Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
title_sort corrigendum to “selective progesterone receptor modulators for the medical treatment of uterine fibroids with a focus on ulipristal acetate”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304190/
https://www.ncbi.nlm.nih.gov/pubmed/30622959
http://dx.doi.org/10.1155/2018/6124628
work_keys_str_mv AT rabethomas corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT saengernicole corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT ebertandreasd corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT roemerthomas corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT tinneberghansrudolf corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT dewilderudyleon corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate
AT wallwienermarkus corrigendumtoselectiveprogesteronereceptormodulatorsforthemedicaltreatmentofuterinefibroidswithafocusonulipristalacetate